Edward J Dulac III sold $84K of NTLA stock

Edward J Dulac III, EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA), sold 4,677 shares of NTLA stock worth $84K, per an SEC Form 4 filed Jul 6, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 2, 2026, 4 days before it was made public.

NTLA has moved -35.0% since the trade date, from $17.56 to $11.41 (Nov 11, 2026 close).